CapsoVision, Inc. (CV) vs Treace Medical Concepts, Inc. (TMCI)
- CapsoVision, Inc. CV 6.36 +2.58%
- Treace Medical Concepts, Inc. TMCI 3.84 −8.13%
CapsoVision, Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $329.9M against $271.9M — 1.2× the size. CapsoVision, Inc. grew revenue faster over the last twelve months: 16.7% against −3.95%. Treace Medical Concepts, Inc. has the higher net margin (−29.0% vs −214.7%) and the higher return on invested capital (−43.0% vs −460.9%). Across the 17 metrics below, Treace Medical Concepts, Inc. leads on 10 and CapsoVision, Inc. on 7.
Valuation
Profitability
| Metric | CV | TMCI | Medical Devices median |
|---|---|---|---|
| Gross margin | 50.88% | 79.45% | 57.76% |
| Operating margin | (217.09%) | (26.17%) | (15.07%) |
| Net margin | (214.74%) | (28.99%) | (14.45%) |
| Free cash flow margin | (200.77%) | (12.20%) | (3.88%) |
| Return on equity | 47.42% | (71.99%) | (10.35%) |
| Return on assets | (212.19%) | (30.72%) | (17.26%) |
| Return on invested capital | (460.93%) | (42.96%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack